日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cerebral Circulation and Brain Temperature during an Ultra-Short Session of Dry Immersion in Young Subjects

年轻受试者在超短时间干式浸泡过程中脑循环和脑温的变化

Gerasimova-Meigal, Liudmila; Meigal, Alexander; Gerasimova, Maria; Sklyarova, Anna; Sirotinina, Ekaterina

PPARγ agonist-induced fluid retention depends on αENaC expression in connecting tubules

PPARγ激动剂诱导的液体潴留依赖于连接小管中αENaC的表达。

Fu, Yiling; Gerasimova, Maria; Batz, Falk; Kuczkowski, Alexander; Alam, Yasaman; Sanders, Paul W; Ronzaud, Caroline; Hummler, Edith; Vallon, Volker

SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice

SGLT2抑制剂恩格列净可降低糖尿病Akita小鼠的肾脏生长和蛋白尿,且降低程度与高血糖水平成正比,并可预防肾小球高滤过。

Vallon, Volker; Gerasimova, Maria; Rose, Michael A; Masuda, Takahiro; Satriano, Joseph; Mayoux, Eric; Koepsell, Hermann; Thomson, Scott C; Rieg, Timo

Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus.

敲除钠-葡萄糖转运蛋白 SGLT2 可减轻糖尿病患者的高血糖和肾小球高滤过,但不会造成肾脏生长或损伤

Vallon Volker, Rose Michael, Gerasimova Maria, Satriano Joseph, Platt Kenneth A, Koepsell Hermann, Cunard Robyn, Sharma Kumar, Thomson Scott C, Rieg Timo

Expression of Na+-D-glucose cotransporter SGLT2 in rodents is kidney-specific and exhibits sex and species differences

啮齿动物中钠-葡萄糖协同转运蛋白SGLT2的表达具有肾脏特异性,并存在性别和物种差异。

Sabolic, Ivan; Vrhovac, Ivana; Eror, Daniela Balen; Gerasimova, Maria; Rose, Michael; Breljak, Davorka; Ljubojevic, Marija; Brzica, Hrvoje; Sebastiani, Anne; Thal, Serge C; Sauvant, Christoph; Kipp, Helmut; Vallon, Volker; Koepsell, Hermann